IFM Investors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.8M Buy
226,534
+19,447
+9% +$326K 0.04% 405
2025
Q1
$3.18M Hold
207,087
0.03% 430
2024
Q4
$4.56M Sell
207,087
-23,941
-10% -$528K 0.05% 353
2024
Q3
$4.16M Buy
231,028
+8,285
+4% +$149K 0.04% 397
2024
Q2
$3.62M Buy
222,743
+8,702
+4% +$141K 0.04% 411
2024
Q1
$3.02M Buy
214,041
+30,270
+16% +$427K 0.03% 450
2023
Q4
$1.92M Hold
183,771
0.02% 501
2023
Q3
$1.87M Buy
183,771
+5,075
+3% +$51.8K 0.02% 516
2023
Q2
$1.35M Buy
178,696
+9,821
+6% +$74K 0.02% 568
2023
Q1
$1.49M Buy
168,875
+2,041
+1% +$18.1K 0.02% 546
2022
Q4
$1.52M Sell
166,834
-1,825
-1% -$16.6K 0.03% 521
2022
Q3
$1.36M Buy
168,659
+3,313
+2% +$26.7K 0.02% 528
2022
Q2
$1.24M Hold
165,346
0.02% 546
2022
Q1
$1.55M Buy
165,346
+30,190
+22% +$284K 0.02% 527
2021
Q4
$1.08M Hold
135,156
0.02% 571
2021
Q3
$1.32M Buy
135,156
+919
+0.7% +$8.95K 0.03% 531
2021
Q2
$1.33M Hold
134,237
0.03% 554
2021
Q1
$1.55M Buy
134,237
+36,934
+38% +$426K 0.04% 438
2020
Q4
$939K Sell
97,303
-1,652
-2% -$15.9K 0.03% 511
2020
Q3
$892K Buy
98,955
+11,680
+13% +$105K 0.04% 434
2020
Q2
$1.08M Sell
87,275
-47,562
-35% -$586K 0.06% 329
2020
Q1
$1.15M Buy
134,837
+47,649
+55% +$405K 0.05% 349
2019
Q4
$854K Sell
87,188
-1,352
-2% -$13.2K 0.03% 511
2019
Q3
$609K Buy
88,540
+29,740
+51% +$205K 0.02% 556
2019
Q2
$543K Buy
58,800
+2,402
+4% +$22.2K 0.03% 516
2019
Q1
$884K Hold
56,398
0.06% 363
2018
Q4
$870K Buy
56,398
+6,275
+13% +$96.8K 0.07% 287
2018
Q3
$1.08M Buy
50,123
+6,823
+16% +$147K 0.08% 247
2018
Q2
$1.05M Buy
43,300
+14,960
+53% +$364K 0.1% 215
2018
Q1
$484K Buy
28,340
+3,089
+12% +$52.8K 0.07% 320
2017
Q4
$479K Hold
25,251
0.08% 299
2017
Q3
$444K Buy
25,251
+528
+2% +$9.28K 0.07% 306
2017
Q2
$821K Buy
24,723
+6,314
+34% +$210K 0.15% 163
2017
Q1
$591K Buy
18,409
+6,853
+59% +$220K 0.15% 162
2016
Q4
$419K Buy
+11,556
New +$419K 0.2% 131